Grifols, S.A. (GRFS)

Today's Latest Price: $18.20 USD

0.83 (-4.36%)

Updated Oct 22 4:00pm

Add GRFS to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 240 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

Grifols SA (GRFS) Price Targets From Analysts

Use the tables below to see what analysts covering Grifols SA think about its future price and what recommendations they have for investors and traders.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
1 $38.75 $38.75 $38.75 $19.03 103.63%

GRFS Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.25 4 1 1 0 0 6

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for GRFS as an investment opportunity.

  • Grifols SA's number of analysts covering the stock is higher than nearly none of all US stocks.
  • GRFS has a less variance in analysts' estimates than nearly 100% of all US stocks.
  • GRFS has a lower percent of analysts bearish on the stock than nearly 100% of all US stocks.
  • Grifols SA's upside potential (average analyst target price relative to current price) is greater than 96.72% of stocks in the large market cap category.
  • Grifols SA's percentage of analysts bullish on the stock is higher than 89.01% of stocks in the large market cap category.
  • The average analyst price target of GRFS is greater than 73.65% of Pharmaceutical Products stocks.
  • Grifols SA's change in bullishness amongst analysts is less than nearly 100% of all US stocks.

In the Pharmaceutical Products industry, CBIO, TLC and SURF are the three stocks most similar to Grifols SA regarding the price target and analyst recommendation information presented here.

Is GRFS a Buy, Hold or Sell? See the POWR Ratings now!



Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.5763 seconds.